Drugs Made In America Acquisition Corp.
$10.53
▲
0.1%
2026-04-21 06:27:00
dmaacorp.com
NGM: DMAA
Explore Drugs Made In America Acquisition Corp. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$355.04 M
Current Price
$10.53
52W High / Low
$10.55 / $10.03
Stock P/E
65.17
Book Value
$-0.22
Dividend Yield
—
ROCE
—
ROE
—
Face Value
—
EPS
—
Exp Qtr EPS
—
Sector
Financial Services
Industry
Shell Companies
Employees
—
Beta
—
Debt / Equity
—
Current Ratio
0.06
Quick Ratio
0.01
Forward P/E
—
Price / Sales
—
Enterprise Value
$352.43 M
EV / EBITDA
—
EV / Revenue
—
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Core market and financial snapshot is available for screening.
Cons
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Aldabra 4 Liquidity Opportunity Vehicle, Inc. | $9.88 | — | $370.69 M | — | 147.1% | 147.1% | $9.9 / $9.82 | $-0.01 |
| 2. | Legato Merger Corp. III | $11.04 | 30 | $236.9 M | — | — | 3.78% | $11.5 / $10.46 | $-0.24 |
| 3. | Oaktree Acquisition Corp. III Life Sciences | $10.64 | — | $262.54 M | — | -0.59% | 3.74% | $10.74 / $10.04 | $-0.28 |
| 4. | American Exceptionalism Acquisi | $11.22 | — | $550.99 M | — | — | — | $11.91 / $10.49 | $-1.33 |
| 5. | Soulpower Acquisition Corporation | $10.33 | 58.66 | $349.72 M | — | -0.65% | 2.42% | $11.65 / $9.98 | $-0.32 |
| 6. | Jackson Acquisition Company II | $10.56 | 27.81 | $253.53 M | — | -0.23% | 18.04% | $10.65 / $10.07 | $0.01 |
| 7. | Quartzsea Acquisition Corporati | $10.39 | — | $118.55 M | — | -2.25% | 0.63% | $10.4 / $9.96 | $-0.34 |
Quarterly Results
Figures shown in M / B
| Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | |
|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0 M |
| Operating Profit | -0.26 M | -0.13 M | -0.33 M | -0.14 M |
| Net Profit | 2.18 M | 2.29 M | 1.25 M | -0.14 M |
| EPS in Rs | 0.07 | 0.07 | 0.04 | -0 |
Profit & Loss
Figures shown in M / B
| 2024 | |
|---|---|
| Sales | — |
| Operating Profit | — |
| Net Profit | — |
| EPS in Rs | — |
Balance Sheet
Figures shown in M / B
| 2024 | |
|---|---|
| Total Assets | 0.55 M |
| Total Liabilities | 0.8 M |
| Equity | -0.24 M |
| Current Assets | 0 M |
| Current Liabilities | 0.8 M |
Cash Flow
Last available yearly cash flow history
| Operating CF |
|---|
| Investing CF |
| Financing CF |
| Free CF |
| Capex |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| Revenue Growth % |
|---|
| Earnings Growth % |
| Profit Margin % |
| Operating Margin % |
| Gross Margin % |
| EBITDA Margin % |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.